{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:57Z","timestamp":1790776377190,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00345-017-2025-5","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T06:14:38Z","timestamp":1488435278000},"page":"1549-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series"],"prefix":"10.1007","volume":"35","author":[{"given":"Noah E.","family":"Canvasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron H.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S. C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Ozayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Trimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Cadeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"issue":"13","key":"2025_CR1","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/cncr.25002","volume":"116","author":"CR Tracy","year":"2010","unstructured":"Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA (2010) Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116(13):3135\u20133142","journal-title":"Cancer"},{"issue":"3","key":"2025_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","volume":"63","author":"SP Psutka","year":"2013","unstructured":"Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63(3):486\u2013492","journal-title":"Eur Urol"},{"issue":"6","key":"2025_CR3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.eururo.2012.01.001","volume":"61","author":"EO Olweny","year":"2012","unstructured":"Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61(6):1156\u20131161","journal-title":"Eur Urol"},{"issue":"5","key":"2025_CR4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.urology.2013.10.081","volume":"83","author":"EH Kim","year":"2014","unstructured":"Kim EH, Tanagho YS, Saad NE, Bhayani SB, Figenshau RS (2014) Comparison of laparoscopic and percutaneous cryoablation for treatment of renal masses. Urology 83(5):1081\u20131087","journal-title":"Urology"},{"issue":"4","key":"2025_CR5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.juro.2015.03.128","volume":"194","author":"PA Caputo","year":"2015","unstructured":"Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O\u2019Malley C, Remer EM, Kaouk JH (2015) Laparoscopic cryoablation for renal cell carcinoma: 100-month oncologic outcomes. J Urol 194(4):892\u2013896","journal-title":"J Urol"},{"issue":"1","key":"2025_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jvir.2011.09.008","volume":"23","author":"TD Atwell","year":"2012","unstructured":"Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE (2012) Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol 23(1):48\u201354","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"2025_CR7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.juro.2011.11.096","volume":"187","author":"SL Best","year":"2012","unstructured":"Best SL, Park SK, Youssef RF, Yaacoub RF, Olweny EO, Tan YK, Trimmer C, Cadeddu JA (2012) Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol 187(4):1183\u20131189","journal-title":"J Urol"},{"issue":"9","key":"2025_CR8","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s00330-009-1399-1","volume":"19","author":"BK Park","year":"2009","unstructured":"Park BK, Kim CK (2009 Sep) Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 19(9):2180\u20132190","journal-title":"Eur Radiol"},{"issue":"3","key":"2025_CR9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.juro.2015.03.115","volume":"194","author":"AH Lay","year":"2015","unstructured":"Lay AH, Faddegon S, Olweny EO, Morgan M, Lorber G, Trimmer C, Leveillee R, Cadeddu JA, Gahan JC (2015) Oncologic efficacy of radio frequency ablation for small renal masses: clear cell vs papillary subtype. J Urol 194(3):653\u2013657","journal-title":"J Urol"},{"issue":"2","key":"2025_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","volume":"33","author":"RV Davalos","year":"2005","unstructured":"Davalos RV, Mir ILM, Rubinsky B (2005 Feb) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223\u2013231","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"2025_CR11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","volume":"177","author":"J Gehl","year":"2003","unstructured":"Gehl J (2003 Apr) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177(4):437\u2013447","journal-title":"Acta Physiol Scand"},{"issue":"7","key":"2025_CR12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1109\/TBME.2006.873745","volume":"53","author":"JF Edd","year":"2006","unstructured":"Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE T Bio-Med Eng 53(7):1409\u20131415","journal-title":"IEEE T Bio-Med Eng"},{"issue":"3","key":"2025_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jamcollsurg.2012.04.029","volume":"215","author":"TP Kingham","year":"2012","unstructured":"Kingham TP, Karkar AM, D\u2019Angelica MI, Allen PJ, Dematteo RP, Getrajdman GI, Sofocleous CT, Solomon SB, Jarnagin WR, Fong Y (2012) Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg 215(3):379\u2013387","journal-title":"J Am Coll Surg"},{"issue":"3","key":"2025_CR14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","volume":"262","author":"RCG Martin","year":"2015","unstructured":"Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, McMasters KM, Watkins K (2015 Sep) Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 262(3):486\u2013494","journal-title":"Ann Surg"},{"issue":"1","key":"2025_CR15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/pcan.2015.47","volume":"19","author":"F Ting","year":"2016","unstructured":"Ting F, Tran M, B\u00f6hm M, Siriwardana A, Van Leeuwen PJ, Haynes A-M, Delprado W, Shnier R, Stricker PD (2016) Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control. Prostate Canc P D 19(1):46\u201352","journal-title":"Prostate Canc P D"},{"issue":"3","key":"2025_CR16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.urology.2010.08.036","volume":"77","author":"A Deodhar","year":"2011","unstructured":"Deodhar A, Monette S, Single GW, Hamilton WC, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3):754\u2013760","journal-title":"Urology"},{"issue":"12","key":"2025_CR17","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1464-410X.2010.09797.x","volume":"107","author":"CR Tracy","year":"2011","unstructured":"Tracy CR, Kabbani W, Cadeddu JA (2011) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 107(12):1982\u20131987","journal-title":"BJU Int"},{"issue":"3","key":"2025_CR18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.urology.2012.11.026","volume":"81","author":"EO Olweny","year":"2013","unstructured":"Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JA (2013) Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology 81(3):679\u2013684","journal-title":"Urology"},{"issue":"1","key":"2025_CR19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00270-010-9964-1","volume":"34","author":"M Pech","year":"2011","unstructured":"Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, Ricke J, Liehr U-B (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Inter Rad 34(1):132\u2013138","journal-title":"Cardiovasc Inter Rad"},{"issue":"39","key":"2025_CR20","first-page":"239","volume":"4","author":"JJ Wendler","year":"2015","unstructured":"Wendler JJ, Ricke J, Pech M, Fischbach F, J\u00fcrgens J, Siedentopf S, Roessner A, Porsch M, Baumunk D, Schostak M, K\u00f6llermann J, Liehr U-B (2015) First delayed resection findings after irreversible electroporation (IRE) of human localised renal cell carcinoma (RCC) in the IRENE Pilot Phase 2a trial. Cardiovasc Inter Rad 4(39):239\u2013250.","journal-title":"Cardiovasc Inter Rad"},{"issue":"9","key":"2025_CR21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jvir.2016.03.044","volume":"27","author":"SJ Diehl","year":"2016","unstructured":"Diehl SJ, Rathmann N, Kostrzewa M, Ritter M, Smakic A, Schoenberg SO, Kriegmair MC (2016) Irreversible electroporation for surgical renal masses in solitary kidneys: short-term interventional and functional outcome. J Vasc Interv Radiol 27(9):1407\u20131413","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"2025_CR22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jvir.2015.06.028","volume":"26","author":"CK Trimmer","year":"2015","unstructured":"Trimmer CK, Khosla A, Morgan M, Stephenson SL, Ozayar A, Cadeddu JA (2015 Oct) Minimally invasive percutaneous treatment of small renal tumors with irreversible electroporation: a single-center experience. J Vasc Interv Radiol 26(10):1465\u20131471","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"2025_CR23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG (2009) The R.E.N.A.L nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844\u2013853","journal-title":"J Urol"},{"key":"2025_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.juro.2013.04.121","volume":"190","author":"SM Donat","year":"2013","unstructured":"Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH, Herrell SD, Hilton S, Jonasch E, Lin DW, Reuter VE, Chang SS (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190:407\u2013416","journal-title":"J Urol"},{"issue":"2","key":"2025_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A (2004 Aug) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213","journal-title":"Ann Surg"},{"key":"2025_CR26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","volume":"182","author":"SC Campbell","year":"2009","unstructured":"Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG, Practice Guidelines Committee of the American Urological Association (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271\u20131279","journal-title":"J Urol"},{"issue":"5","key":"2025_CR27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913\u2013924","journal-title":"Eur Urol"},{"issue":"5","key":"2025_CR28","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.juro.2008.07.047","volume":"180","author":"PL Crispen","year":"2008","unstructured":"Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC (2008) Outcomes following partial nephrectomy by tumor size. J Urol 180(5):1912\u20131917","journal-title":"J Urol"},{"issue":"7","key":"2025_CR29","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00330-013-2784-3","volume":"23","author":"P Balageas","year":"2013","unstructured":"Balageas P, Cornelis F, Le Bras Y, Hubrecht R, Bernhard JC, Ferri\u00e8re JM, Ravaud A, Grenier N (2013) Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients. Eur Radiol 23(7):1925\u20131932","journal-title":"Eur Radiol"},{"issue":"4","key":"2025_CR30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.urology.2015.01.004","volume":"85","author":"H Zargar","year":"2015","unstructured":"Zargar H, Samarasekera D, Khalifeh A, Remer EM, O\u2019Malley C, Akca O, Autorino R, Kaouk JH (2015 Apr) Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology 85(4):850\u2013855","journal-title":"Urology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-017-2025-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2025-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T06:05:28Z","timestamp":1506319528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-017-2025-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s00345-017-2025-5","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}